Cleared Traditional

K882923 - KODAK SURECELL CHLAMYDIA TEST KIT

K882923 is an FDA 510(k) clearance for KODAK SURECELL CHLAMYDIA TEST KIT, manufactured by Eastman Kodak Company. The device is a Class 1 Microbiology device with product code LJC cleared through the Traditional 510(k) pathway after a 120-day FDA review.

K882923 · Eastman Kodak Company · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1988
Decision
120d
Days
Class 1
Risk

K882923 is an FDA 510(k) clearance for the KODAK SURECELL CHLAMYDIA TEST KIT. Classified as Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group) (product code LJC), Class I - General Controls.

Submitted by Eastman Kodak Company (Rochester, US). The FDA issued a Cleared decision on November 10, 1988 after a review of 120 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3120 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Eastman Kodak Company devices

FDA 510(k) Submission Details - K882923

510(k) Number K882923 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 13, 1988
Decision Date November 10, 1988
Days to Decision 120 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
18d slower than avg
Panel avg: 102d · This submission: 120d
Pathway characteristics
Predicate-based equivalence.

LJC Device Classification - Class 1, General Controls

Product Code LJC Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3120
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LJC Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group)

All 52
Devices cleared under the same product code (LJC) and FDA review panel - the closest regulatory comparables to K882923.
CHLAMYDIAZYME/COMMANDER INSTRUMENTATION
K885006 · Abbott Laboratories · Dec 1988
MODIFIED IDEIA CHLAMYDIA TEST
K880799 · Boots-Celltech Diagnostics, Inc. · Dec 1988
PATHFINDER(TM) CHLAMYDIA EIA DETECT KIT/MODIFIED
K884517 · Kallestad Diag, A Div. of Erbamont, Inc. · Nov 1988
PHARMACIA CHLAMYDIA EIA
K882676 · Pharmacia, Inc. · Aug 1988
ABBOTT TESTPACK CHLAMYDIA
K880783 · Abbott Laboratories · Jul 1988
ABBOTT TESTPACK(TM) CHLAMYDIA POSITIVE CONTROL
K882535 · Abbott Laboratories · Jul 1988